Wealthfront Advisers’s Hologic HOLX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-61,471
Closed -$4.65M 1125
2026
Q1
$4.65M Buy
61,471
+561
+0.9% +$42.2K 0.01% 435
2025
Q4
$4.54M Buy
60,910
+230
+0.4% +$16.8K 0.01% 425
2025
Q3
$4.1M Sell
60,680
-18,960
-24% -$1.26M 0.01% 429
2025
Q2
$5.19M Buy
79,640
+34,557
+77% +$2.07M 0.01% 371
2025
Q1
$2.78M Buy
45,083
+33,833
+301% +$2.24M 0.01% 456
2024
Q4
$811K Buy
11,250
+599
+6% +$46.8K ﹤0.01% 704
2024
Q3
$868K Buy
10,651
+1,268
+14% +$101K ﹤0.01% 669
2024
Q2
$697K Sell
9,383
-862
-8% -$64.6K ﹤0.01% 691
2024
Q1
$799K Buy
10,245
+178
+2% +$13.2K ﹤0.01% 655
2023
Q4
$719K Sell
10,067
-13,811
-58% -$962K ﹤0.01% 649
2023
Q3
$1.66M Sell
23,878
-12,785
-35% -$966K 0.01% 461
2023
Q2
$2.97M Sell
36,663
-825
-2% -$67.4K 0.01% 329
2023
Q1
$3.03M Sell
37,488
-1,035
-3% -$83.3K 0.01% 315
2022
Q4
$2.88M Sell
38,523
-4,949
-11% -$352K 0.01% 301
2022
Q3
$2.81M Buy
43,472
+326
+0.8% +$22.6K 0.01% 286
2022
Q2
$2.99M Buy
43,146
+1,752
+4% +$130K 0.02% 282
2022
Q1
$3.18M Buy
41,394
+36,468
+740% +$2.62M 0.01% 289
2021
Q4
$377K Sell
4,926
-12,830
-72% -$943K ﹤0.01% 639
2021
Q3
$1.31M Buy
17,756
+13,810
+350% +$1.04M 0.01% 429
2021
Q2
$263K Sell
3,946
-6,742
-63% -$451K ﹤0.01% 587
2021
Q1
$795K Buy
10,688
+3,362
+46% +$255K ﹤0.01% 407
2020
Q4
$534K Buy
7,326
+4,205
+135% +$297K ﹤0.01% 431
2020
Q3
$207K Buy
+3,121
New +$198K ﹤0.01% 502
2019
Q4
Sell
-10,148
Closed -$512K 496
2019
Q3
$512K Buy
+10,148
New +$499K ﹤0.01% 377

Other funds holding HOLX

Wealthfront Advisers's HOLX Position: Q2 2026 in Review

Wealthfront Advisers sold out of Hologic (HOLX) in Q2 2026, closing a stake of 61,471 shares — an estimated $4.65M sold.

Wealthfront Advisers first reported a position in HOLX in Q3 2019 and held it in 24 quarters. The position peaked at $5.19M in Q2 2025. 3 funds tracked by Wall St. Rank hold HOLX as of Q2 2026.

  • Wealthfront Advisers reported no remaining Hologic position as of Q2 2026 after selling out during the quarter.
  • Wealthfront Advisers sold 61,471 Hologic shares in Q2 2026, an estimated $4.65M.
  • Wealthfront Advisers first reported a position in Hologic in Q3 2019 and held it in 24 quarters.
  • Wealthfront Advisers's Hologic position peaked at $5.19M in Q2 2025.
  • 3 funds tracked by Wall St. Rank held Hologic as of Q2 2026.

Based on Wealthfront Advisers's 13F filing for Q2 2026, filed 7 Aug 2026.